Switch to:
Also traded in: Delisted, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.07
NYSE:PAH's Cash-to-Debt is ranked lower than
92% of the 1156 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.96 vs. NYSE:PAH: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:PAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.09 Max: 0.86
Current: 0.07
0.06
0.86
Equity-to-Asset 0.27
NYSE:PAH's Equity-to-Asset is ranked lower than
90% of the 1112 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. NYSE:PAH: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:PAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.27 Max: 0.55
Current: 0.27
0.21
0.55
Debt-to-Equity 1.97
NYSE:PAH's Debt-to-Equity is ranked lower than
94% of the 867 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.39 vs. NYSE:PAH: 1.97 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:PAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.49  Med: 1.84 Max: 2.64
Current: 1.97
0.49
2.64
Debt-to-EBITDA 11.02
NYSE:PAH's Debt-to-EBITDA is ranked lower than
94% of the 932 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.03 vs. NYSE:PAH: 11.02 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:PAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.44  Med: 13.47 Max: 16.75
Current: 11.02
4.44
16.75
Interest Coverage 1.20
NYSE:PAH's Interest Coverage is ranked lower than
98% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 35.14 vs. NYSE:PAH: 1.20 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:PAH' s Interest Coverage Range Over the Past 10 Years
Min: 0.25  Med: 0.93 Max: 2.35
Current: 1.2
0.25
2.35
Piotroski F-Score: 4
Altman Z-Score: 0.73
Beneish M-Score: -2.47
WACC vs ROIC
12.48%
6.40%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % 10.24
NYSE:PAH's Operating Margin % is ranked lower than
62% of the 1134 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.97 vs. NYSE:PAH: 10.24 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:PAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.13  Med: 8.09 Max: 15.78
Current: 10.24
1.13
15.78
Net Margin % -6.05
NYSE:PAH's Net Margin % is ranked lower than
92% of the 1132 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.06 vs. NYSE:PAH: -6.05 )
Ranked among companies with meaningful Net Margin % only.
NYSE:PAH' s Net Margin % Range Over the Past 10 Years
Min: -12.14  Med: -2.81 Max: 6.29
Current: -6.05
-12.14
6.29
ROE % -8.25
NYSE:PAH's ROE % is ranked lower than
92% of the 1122 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.58 vs. NYSE:PAH: -8.25 )
Ranked among companies with meaningful ROE % only.
NYSE:PAH' s ROE % Range Over the Past 10 Years
Min: -15.1  Med: -10.81 Max: 1.03
Current: -8.25
-15.1
1.03
ROA % -2.26
NYSE:PAH's ROA % is ranked lower than
89% of the 1161 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.02 vs. NYSE:PAH: -2.26 )
Ranked among companies with meaningful ROA % only.
NYSE:PAH' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: -0.88 Max: 7.46
Current: -2.26
-4.19
7.46
ROC (Joel Greenblatt) % 11.03
NYSE:PAH's ROC (Joel Greenblatt) % is ranked higher than
55% of the 1158 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.47 vs. NYSE:PAH: 11.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:PAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1.34  Med: 4.37 Max: 104.33
Current: 11.03
-1.34
104.33
3-Year Revenue Growth Rate 28.40
NYSE:PAH's 3-Year Revenue Growth Rate is ranked higher than
96% of the 1050 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.60 vs. NYSE:PAH: 28.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:PAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.95 Max: 28.4
Current: 28.4
0
28.4
3-Year EBITDA Growth Rate 26.50
NYSE:PAH's 3-Year EBITDA Growth Rate is ranked higher than
89% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.90 vs. NYSE:PAH: 26.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:PAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -11.75 Max: 26.5
Current: 26.5
0
26.5
3-Year EPS without NRI Growth Rate 18.80
NYSE:PAH's 3-Year EPS without NRI Growth Rate is ranked higher than
62% of the 894 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.10 vs. NYSE:PAH: 18.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:PAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.8
Current: 18.8
0
18.8
GuruFocus has detected 1 Warning Sign with Platform Specialty Products Corp NYSE:PAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:PAH's 30-Y Financials

Financials (Next Earnings Date: 2018-08-09)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

PAH Guru Trades in Q2 2017

Joel Greenblatt 111,082 sh (+504.10%)
Jim Simons 783,172 sh (+122.56%)
Paul Tudor Jones 852,097 sh (+22.39%)
Larry Robbins 13,203,633 sh (+17.85%)
Paul Singer 10,951,281 sh (unchged)
Caxton Associates 100,000 sh (unchged)
Mario Gabelli 65,000 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
George Soros Sold Out
Chuck Royce 96,000 sh (-4.00%)
John Griffin 10,711,700 sh (-16.22%)
Murray Stahl 618,756 sh (-30.39%)
» More
Q3 2017

PAH Guru Trades in Q3 2017

Larry Robbins 14,328,633 sh (+8.52%)
Mario Gabelli 65,000 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Chuck Royce 92,200 sh (-3.96%)
Murray Stahl 587,157 sh (-5.11%)
Jim Simons 692,699 sh (-11.55%)
John Griffin 9,335,000 sh (-12.85%)
Paul Tudor Jones 661,925 sh (-22.32%)
Joel Greenblatt 15,530 sh (-86.02%)
» More
Q4 2017

PAH Guru Trades in Q4 2017

Chuck Royce 720,108 sh (+681.03%)
Jim Simons 1,675,300 sh (+141.85%)
Mario Gabelli 65,000 sh (unchged)
Larry Robbins 14,328,633 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
John Griffin Sold Out
Joel Greenblatt Sold Out
Murray Stahl 491,508 sh (-16.29%)
Paul Tudor Jones 160,510 sh (-75.75%)
» More
Q1 2018

PAH Guru Trades in Q1 2018

Joel Greenblatt 21,746 sh (New)
David Tepper 3,798,055 sh (New)
Paul Tudor Jones 281,008 sh (+75.07%)
Bill Ackman 40,451,506 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Chuck Royce 720,108 sh (unchged)
Mario Gabelli 65,000 sh (unchged)
Murray Stahl 483,163 sh (-1.70%)
Larry Robbins 13,411,427 sh (-6.40%)
Jim Simons 19,700 sh (-98.82%)
» More
» Details

Insider Trades

Latest Guru Trades with PAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Tepper 2018-03-31 New Buy0.38%$9.59 - $11.95 $ 12.5518%3,798,055
Joel Greenblatt 2018-03-31 New Buy$9.59 - $11.95 $ 12.5518%21,746
Joel Greenblatt 2017-12-31 Sold Out $9.45 - $11.7 $ 12.5521%0
Joel Greenblatt 2017-09-30 Reduce -86.02%0.02%$10.92 - $14.58 $ 12.551%15,530
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325998    SIC: 2899
Compare:NYSE:SXT, NYSE:KRO, LSE:VCT, SZSE:002648, SHSE:600873, BOM:500870, TSE:4118, TSE:4631, NYSE:NGVT, NYSE:FUL, OSTO:HPOL B, SZSE:002709, BKK:TOA, TSE:4403, LSE:SYNT, XAMS:IMCD, NYSE:POL, NYSE:CBT, NYSE:GCP, TSE:4202 » details
Traded in other countries:PAH.Delisted, PLQ.Germany,
Headquarter Location:USA
Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Platform Specialty Products Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into two segments based on product type. The agricultural solutions segment, which generates the majority of revenue, sells fungicides, herbicides, insecticides, and seed treatments to the agriculture industry. The performance solutions segment sells chemicals used in the production of circuit boards, as well as metal and plastic finishes for the automotive and oil and gas industries. The segment also sells printing plates used for the commercial packaging of food products, boxes, and labels. More revenue is generated in the United States than any other geography.

Guru Investment Theses on Platform Specialty Products Corp

Bill Ackman Comments on Platform Specialty Products Corp - May 17, 2018

Platform Specialty Products Corporation (NYSE:PAH)

Platform reported continued earnings growth this quarter as the combination of organic revenue growth, lower interest expense and a strong tailwind from foreign exchange more than offset temporary margin pressures from input cost inflation. Platform’s organic revenue grew 5% as Performance Solutions grew 4%, and Ag Solutions grew 6%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronic materials business it acquired from Alent, and overall strength in its industrial business. The growth in Ag Solutions was driven by strength in the Latin and North American markets.

Despite positive organic sales growth, Platform’s organic EBITDA decreased 3% due to input cost inflation in Ag Solutions, which the company expects to mitigate through future price increases. Performance Solutions organic EBITDA grew 2% as positive revenue growth was somewhat offset by the increased proportion of sales from lower-margin products. Ag Solutions organic EBITDA declined 8% due to input cost inflation resulting from supply shortages of key active ingredients and a higher level of sales from lower-margin products. Platform’s overall EBITDA grew 7% due to a 10% tailwind from foreign exchange. EPS increased 30% due to lower interest expense from the company’s recent debt refinancing.

On Platform’s earnings call, management reiterated that it remains on track to separate its two businesses in the second half of this year, and stated that it is evaluating various execution alternatives for the separation in order to maximize shareholder value.

From Bill Ackman (Trades, Portfolio)'s first-quarter 2018 shareholder letter.



Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform - Nov 16, 2017

Platform (NYSE:PAH)’s earnings continued to grow this quarter as growth in the Performance Solutions business offset a decline in the Ag Solutions business. Platform’s organic revenue declined 1%, as Performance Solutions grew 4% and Ag Solutions declined 5%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The decline in Ag Solutions resulted primarily from the ongoing drought in Brazil, which has caused buyers to delay their typical purchases in advance of the planting season. If the drought abates within the next few months, management believes it is likely it will recover these sales in future quarters.

Platform’s organic EBITDA increased 1%. Performance Solutions organic EBITDA grew 4% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA declined 3%, as the portion of sales from higher-margin products increased and the company continued to reduce structural costs.

Platform’s overall EBITDA grew 3% due to a 2% tailwind from foreign exchange. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 18%.

At the end of August, Platform announced that it intends to separate its Ag and Performance Solutions businesses into two publicly traded companies in order to increase long-term value. Management expects the separation to occur by the middle of next year, and is likely be effectuated by an IPO of the Ag business.


From Bill Ackman (Trades, Portfolio)'s third quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Aug 18, 2017

Platform (NYSE:PAH) reported strong earnings this quarter due to continued organic revenue growth and positive results from its ongoing cost savings initiatives. Platform’s organic revenue increased 2%, as Performance Solutions grew 6% and Ag Solutions declined 2%. The growth in the Performance Solutions segment was due primarily to the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The modest decline in Ag Solutions resulted from poor weather conditions in Eastern Europe and the restructuring of its business in Africa. Ag Solutions reported positive growth in all of its key regions outside of Eastern Europe and Africa.

Platform’s organic EBITDA increased 8% due to strong results in both segments. Performance Solutions organic EBITDA grew 7% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA grew 9% in spite of the decline in revenue due to increased sales of higher-margin products and continued cost reductions in the business.

Platform’s overall EBITDA grew 6% due to a 2% headwind from the strengthening U.S. dollar. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 25%.

From Bill Ackman (Trades, Portfolio)'s second quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 12, 2017

Platform (NYSE:PAH) reported strong earnings growth for the first quarter. The company generated organic EBITDA growth of 18%, due to revenue growth in both of its businesses and improved cost efficiencies, both at the segment and corporate level. Organic revenue growth was 3%, due to 5% organic growth in Performance Solutions and 2% organic growth in Agricultural Solutions. Performance Solutions showed particular strength this quarter in its industrial and Asian electronics segments, as its end markets have improved and the integration of Alent has helped Platform gain market share. Agricultural Solutions growth was driven by strength in Latin America, but offset somewhat by weakness in Europe due to poor weather.

Performance Solutions organic EBITDA grew 27%, due primarily to further cost synergies from the Alent acquisition and continued cost efficiencies. Agriculture Solutions organic EBITDA grew 8% due primarily to a larger sales mix of higher margin products and cost reductions related to its recently announced $100 million cost savings initiative.

In April, Platform refinanced an additional $1.9 billion of debt reducing its interest costs by 1%. Since last October, the company has refinanced more than $5 billion of debt, lowering the associated interest rate by 1% and extending the maturity on a substantial portion of its debt by three years.



From Bill Ackman (Trades, Portfolio)'s first quarter 2017 shareholder letter.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 08, 2017

2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.

From 2016 annual letter to shareholders of Pershing Square by Bill Ackman (Trades, Portfolio).

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Mar 30, 2017



2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.



From Bill Ackman (Trades, Portfolio)'s Pershing Square 2016 annual report.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Dec 09, 2016

In September, Platform (NYSE:PAH) hosted an investor day where it provided a detailed explanation of the secular growth drivers and unique competitive positioning of each of its Performance and Agricultural Solutions businesses, along with long-term guidance of 4% annual organic revenue growth and high-single digit annual EBITDA growth.

The company also announced that it had reached a revised agreement with Permira to settle its $600 million preferred stock liability related to the Arysta acquisition. Under the revised agreement, Platform has the option to pay Permira $450 million in cash and 5.5 million shares, which equates to $500 million at the current market prices and represents a savings of $100 million relative to the original agreement. To finance the cash portion of the agreement, the company raised $400 million of equity and, as a result, was able to refinance $2 billion of its debt, reducing the rate on this debt by 50 basis points and extending the maturities by three years to 2023.

At the beginning of November, Platform reported strong third quarter earnings. The company delivered 3% organic revenue growth, comprised of 4% growth in Agricultural Solutions and 2% in Performance Solutions. The results are particularly impressive given the cyclical weakness in the company’s end markets. EBITDA grew 14%, due to 5% growth before synergies and corporate costs, 6% impact from net synergies, and 3% from FX.

From Bill Ackman (Trades, Portfolio)'s Pershing Square third-quarter shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Aug 29, 2016

Platform (NYSE:PAH)'s earnings declined in the second quarter as positive results in Performance Solutions, increased cost synergies, and strong growth in the International Ag Solutions were offset by a significant decline in the North American Ag Solutions business and increased corporate costs.

Platform's organic revenue increased 1% as Ag Solutions grew 5% and Performance Solutions revenue declined 2%. Ag Solutions achieved double-digit growth outside of North America (more than 80% of segment revenue), which was offset by a more than 40% decline in North America. The decline in North America resulted from the continued reduction in distributor channel inventories, decreased demand for pesticides due to lower pest pressures, and lower market share. The company stated that it has made changes to its sales force and product development initiatives and expects these efforts to improve business results over time. Performance Solutions' organic revenue declined primarily due to weakness in the electronics market in Asia, which the company noted should return to growth in the second half of the year.

Platform's organic EBITDA was down nearly 6%, as the growth in Performance Solutions and cost synergies were more than offset by the decline in Ag Solutions and higher corporate costs. In Performance Solutions, organic EBITDA increased 4%, as an improved sales mix of higher-margin products and cost synergies more than offset an increase in corporate expenses. In Ag Solutions, organic EBITDA declined 15%, as the higher sales mix of lower-margin products and the declines in the relatively higher-margin North American business more than offset increased cost synergies. Reported EBITDA declined 10% due to the negative headwinds from FX. As a result, EPS declined 36% due to the negative impact of financial leverage.

While Platform delivered mixed performance for the quarter, we are starting to see business progress under Platform's new CEO Rakesh Sachdev. We think highly of Rakesh and believe he possesses the necessary leadership qualities and experience to improve the performance of Platform.

From Bill Ackman (Trades, Portfolio)'s mid-year 2016 letter.

Check out Bill Ackman latest stock trades

Top Ranked Articles about Platform Specialty Products Corp

Market Trends Toward New Normal in Applied Optoelectronics, Integra LifeSciences, Medtronic, Workhorse Group, Platform Specialty Products, and Career Education — Emerging Consolidated Expectations, Analyst Ratings
Platform Enters Exclusive Negotiations with Prospective Acquirer of Arysta LifeScience
Bill Ackman’s Picks Looking Up After several missteps, the hedge fund manager's portfolio is in the green
The year is looking bright for Bill Ackman (Trades, Portfolio), CEO of Pershing Square Capital, as most of his portfolio holdings have posted gains for the year, an event not seen since 2014. Read more...
Platform Responds to Press Speculation Regarding its Agricultural Solutions Segment
Arysta LifeScience Completed the Acquisition of Etec Crop Solutions in New Zealand
Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform Specialty Products Corporation (NYSE:PAH) Read more...
New Research Coverage Highlights CSX, Hewlett Packard Enterprise, Platform Specialty Products, ITT, United Parcel Service, and Hi-Crush Partners LP — Consolidated Revenues, Company Growth, and Expectations for 2018
Platform Specialty Products Corporation to Present at May Investor Conferences
Platform Specialty Products Corporation Announces the Closing of its Acquisition of HiTech Korea Co., Ltd by MacDermid Performance Solutions
Platform Specialty Products Corporation Announces Date for Release of 2018 First Quarter Financial Results

Ratios

vs
industry
vs
history
Forward PE Ratio 13.19
PAH's Forward PE Ratio is ranked higher than
84% of the 107 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.45 vs. PAH: 13.19 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 1.25
PAH's PB Ratio is ranked higher than
74% of the 1120 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.96 vs. PAH: 1.25 )
Ranked among companies with meaningful PB Ratio only.
PAH' s PB Ratio Range Over the Past 10 Years
Min: 0.65  Med: 1.28 Max: 2.71
Current: 1.25
0.65
2.71
PS Ratio 0.92
PAH's PS Ratio is ranked higher than
69% of the 1105 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.35 vs. PAH: 0.92 )
Ranked among companies with meaningful PS Ratio only.
PAH' s PS Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1 Max: 8.72
Current: 0.92
0.48
8.72
Price-to-Free-Cash-Flow 39.85
PAH's Price-to-Free-Cash-Flow is ranked lower than
59% of the 366 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 22.34 vs. PAH: 39.85 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.57  Med: 27.44 Max: 83.09
Current: 39.85
4.57
83.09
Price-to-Operating-Cash-Flow 24.91
PAH's Price-to-Operating-Cash-Flow is ranked lower than
69% of the 475 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.53 vs. PAH: 24.91 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.86  Med: 19.15 Max: 50.4
Current: 24.91
3.86
50.4
EV-to-EBIT 59.79
PAH's EV-to-EBIT is ranked lower than
86% of the 993 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.43 vs. PAH: 59.79 )
Ranked among companies with meaningful EV-to-EBIT only.
PAH' s EV-to-EBIT Range Over the Past 10 Years
Min: -7489.8  Med: 56 Max: 1143.1
Current: 59.79
-7489.8
1143.1
EV-to-EBITDA 17.50
PAH's EV-to-EBITDA is ranked lower than
58% of the 1025 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.05 vs. PAH: 17.50 )
Ranked among companies with meaningful EV-to-EBITDA only.
PAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.2  Med: 31.6 Max: 774.9
Current: 17.5
10.2
774.9
EV-to-Revenue 2.29
PAH's EV-to-Revenue is ranked lower than
62% of the 1121 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.56 vs. PAH: 2.29 )
Ranked among companies with meaningful EV-to-Revenue only.
PAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 2  Med: 2.6 Max: 10.1
Current: 2.29
2
10.1
Current Ratio 2.07
PAH's Current Ratio is ranked higher than
58% of the 1016 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.92 vs. PAH: 2.07 )
Ranked among companies with meaningful Current Ratio only.
PAH' s Current Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.11 Max: 7.71
Current: 2.07
1.66
7.71
Quick Ratio 1.57
PAH's Quick Ratio is ranked higher than
60% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.42 vs. PAH: 1.57 )
Ranked among companies with meaningful Quick Ratio only.
PAH' s Quick Ratio Range Over the Past 10 Years
Min: 1.3  Med: 1.65 Max: 7.02
Current: 1.57
1.3
7.02
Days Inventory 87.49
PAH's Days Inventory is ranked lower than
67% of the 1098 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 63.62 vs. PAH: 87.49 )
Ranked among companies with meaningful Days Inventory only.
PAH' s Days Inventory Range Over the Past 10 Years
Min: 36.92  Med: 79.12 Max: 120.71
Current: 87.49
36.92
120.71
Days Sales Outstanding 121.35
PAH's Days Sales Outstanding is ranked lower than
84% of the 923 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 62.93 vs. PAH: 121.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
PAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.37  Med: 111.75 Max: 146.87
Current: 121.35
69.37
146.87
Days Payable 80.34
PAH's Days Payable is ranked higher than
72% of the 876 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.72 vs. PAH: 80.34 )
Ranked among companies with meaningful Days Payable only.
PAH' s Days Payable Range Over the Past 10 Years
Min: 51.84  Med: 77.08 Max: 106.01
Current: 80.34
51.84
106.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -16.40
PAH's 3-Year Average Share Buyback Ratio is ranked lower than
87% of the 583 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -2.70 vs. PAH: -16.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40  Med: -32.3 Max: -16.4
Current: -16.4
-40
-16.4

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.93
PAH's Price-to-Median-PS-Value is ranked higher than
78% of the 999 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.23 vs. PAH: 0.93 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.56  Med: 1.02 Max: 8.81
Current: 0.93
0.56
8.81
Earnings Yield (Greenblatt) % 1.65
PAH's Earnings Yield (Greenblatt) % is ranked lower than
74% of the 1161 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.33 vs. PAH: 1.65 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1.1  Med: 0.7 Max: 5
Current: 1.65
-1.1
5

More Statistics

Revenue (TTM) (Mil) $3,878.20
EPS (TTM) $ -0.82
Beta2.66
Volatility39.10%
52-Week Range $9.09 - 14.82
Shares Outstanding (Mil)287.40

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 4,004 4,161 4,383
EBIT (Mil $) 752 846 1,178
EBITDA (Mil $) 881 974 1,320
EPS ($) 0.82 1.00 1.50
EPS without NRI ($) 0.82 1.00 1.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}